Clinical Observation: Effect of a Second Transpositioned Variant in a Family with Autosomal Dominant Ryanodine Receptor-1–Related Disease

Abstract

Mutations in the ryanodine receptor-1 (RYR1) may cause disorders inherited in an autosomal dominant/recessive fashion. Sequencing of RYR1 in an infant of Ashkenazi Jewish descent with severe hypotonia, dislocation of hip, torticollis and scoliosis, and paternal family history of autosomal dominant mild disease. The child was compound heterozygote for a missense variant c.7042G > A inherited from her father associated with autosomal dominant disease, and a missense variant of unknown significance c.5309C > T inherited from an asymptomatic mother. This case raises the possibility of a dominant disease complicated by a second variant in the other allele serving as a modifier.

Keywords

central core disease - malignant hyperthermia susceptibility - ryanodine receptor-1 gene

• References

• 1 Jungbluth H. Central core disease. Orphanet J Rare Dis 2007; 2: 25
• 2 Malicdan MCV, Nishino I. Central core disease. In: Adam MP, Ardinger HH, Pagon RA. , et al, eds. GeneReviews. Seattle, WA: University of Washington; 1993
• 3 Romero NB, Monnier N, Viollet L. , et al. Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia. Brain 2003; 126 (Pt 11): 2341-2349
• 4 Beggs AH, Agrawal PB. Multiminicore disease. In: Adam MP, Ardinger HH, Pagon RA. , et al, eds. GeneReviews. Seattle, WA: University of Washington; 1993
• 5 Avila G, O'Connell KM, Dirksen RT. The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease. J Gen Physiol 2003; 121 (04) 277-286
• 6 Rosenberg H, Sambuughin N, Riazi S, Dirksen R. Malignant hyperthermia susceptibility. In: Adam MP, Ardinger HH, Pagon RA. , et al, eds. GeneReviews. Seattle, WA: University of Washington; 1993
• 7 Sambuughin N, Holley H, Muldoon S. , et al. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population. Anesthesiology 2005; 102 (03) 515-521
• 8 Stewart SL, Hogan K, Rosenberg H, Fletcher JE. Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia. Clin Genet 2001; 59 (03) 178-184
• 9 Dirksen RT, Avila G. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1. Biophys J 2004; 87 (05) 3193-3204
• 10 Robinson RL, Brooks C, Brown SL. , et al. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes. Hum Mutat 2002; 20 (02) 88-97
• 11 Remiche G, Kadhim H, Abramowicz M, Mavroudakis N, Monnier N, Lunardi J. A novel large deletion in the RYR1 gene in a Belgian family with late-onset and recessive core myopathy. Neuromuscul Disord 2015; 25 (05) 397-402
• 12 Richards S, Aziz N, Bale S. , et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 13 Sewry CA, Müller C, Davis M. , et al. The spectrum of pathology in central core disease. Neuromuscul Disord 2002; 12 (10) 930-938
• 14 Snoeck M, van Engelen BG, Küsters B. , et al. RYR1-related myopathies: a wide spectrum of phenotypes throughout life. Eur J Neurol 2015; 22 (07) 1094-1112
• 15 Ben-Shachar S, Khajavi M, Withers MA. , et al. Dominant versus recessive traits conveyed by allelic mutations - to what extent is nonsense-mediated decay involved?. Clin Genet 2009; 75 (04) 394-400